Diagnostic Comparison of PET-magnetic Resonance and PET-CT in Patients With Oncologic Diseases

Diagnostic Comparison and Workflow Evaluation of Whole Body PET-magnetic Resonance and PET-CT With and Without Contrast Media in Patients With Oncologic Diseases

Diagnostic accuracy of PET/magnetic resonance and PET/CT will be compared concerning primary tumor, regional nodes, metastasis (TNM) staging and therapeutic influence. Workflow scenarios will be evaluated to create imaging protocols which are time efficient and diagnostically accurate.

Inclusion Criteria:

• Male and female patients from 18-90 years
• Written informed consent
• Patients with a proven or suspected oncological disease referred for a clinically -Indicated PET/CT with of without contrast media

Exclusion Criteria:

• Pregnant or breast feeding women
• Non compliance of the patient to follow the study instructions (e.g. hearing problems, dementia)
• Inclusion in another clinical trial 30 days prior to inclusion
• Age < 30years
• Contraindication for MRI (cardiac pacemaker, certain metal implants, claustrophobia
• Known allergies to contrast CT or MRI contrast media
• Patients with an glomerular filtration rate of < 60ml/min/1.73m2